Nexien BioPharma, Inc. (NXEN)

OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Mar 6, 2026, 4:00 PM EST
-98.57%
Market Cap 7.08K
Revenue (ttm) n/a
Net Income (ttm) -188.08K
Shares Out 70.77M
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 115,000
Average Volume 44,423
Open 0.0018
Previous Close 0.0001
Day's Range 0.0001 - 0.0018
52-Week Range 0.0001 - 0.0145
Beta -1.08
RSI 39.26
Earnings Date Feb 17, 2026

About Nexien BioPharma

Nexien BioPharma, Inc. focuses on the formulation, development, and commercialization of cannabinoid-based pharmaceuticals, drug delivery systems, and related technologies for diseases, disorders, and medical conditions in the United States. The company was formerly known as Intiva BioPharma Inc. and changed its name to Nexien BioPharma, Inc. in September 2018. Nexien BioPharma, Inc. is based in Glendale, Colorado. [Read more]

Sector Healthcare
CEO Richard Greenberg
Employees 3
Stock Exchange OTCMKTS
Ticker Symbol NXEN
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.